C. Sclerosing polycystic adenoma
Microscopically, hematoxylin-eosin–stained sections demonstrated a well-circumscribed solid mass with a lobular architecture. Within the lesion, there was variably abundant, hyalinized collagen surrounding closely packed ductal structures with varying sizes, some of which were cystically dilated. The lining epithelial cells were bland, and mitotic figures were absent. There were frequent clusters of acinar structures with brightly eosinophilic, intracytoplasmic granules. These characteristic histologic features confirmed the diagnosis of sclerosing polycystic adenoma (SPA).
Sclerosing polycystic adenoma is an uncommon salivary gland tumor first described by Smith et al1 in a series of 9 cases using the term sclerosing polycystic adenosis. Since then, this entity has been increasingly recognized, with more than 100 cases reported so far.2,3 Recently, SPA has been included in the latest edition of the World Health Organization classification of head and neck tumors.4 Sclerosing polycystic adenoma was initially considered to be reactive or inflammatory in nature; however, emerging evidence suggests a clonal process,5 a propensity to recur, and rare instances of malignant transformation.2- 4 Therefore, based on the newly recognized findings, the term sclerosing polycystic adenoma has been proposed to reflect a true neoplastic process.2,3 This notion is further supported by the recent discovery of recurrent gene variations in the PI3K pathway of cell cycle regulation in SPA that are analyzed through targeted next-generation sequencing, with PTEN variations identified in all cases (n = 4).6